电子临床解决方案市场 - 全球产业规模、份额、趋势、机会和预测，按产品、交付模式、开发阶段、最终用户、地区和竞争细分，2020-2030 年

2024 年全球电子临床解决方案市值为 105.3 亿美元，预计到 2030 年将达到 237.2 亿美元，复合年增长率为 14.47%。随着製药、生物技术和合约研究组织 (CRO) 越来越多地转向数位工具来更有效地管理复杂的临床试验，全球电子临床解决方案市场正在经历快速转型。随着对更快药物开发的需求日益增加，公司正在寻求简化资料收集、管理和分析的解决方案。电子资料收集 (EDC)、临床试验管理系统 (CTMS)、随机化和试验供应管理 (RTSM) 和电子病患报告结果 (ePRO) 等电子临床平台现已被广泛实施，以确保即时存取关键试验资料并遵守法规。这些解决方案有助于加快决策速度、减少人为错误并改善试验结果，使其成为现代临床研究环境中不可或缺的一部分。

关键的市场驱动因素包括製药和生物技术公司不断增加的研发投入、日益增长的慢性病发病率（需要高级药物开发）以及向分散式临床试验的转变。由于患者招募和保留仍然是临床研究中持续存在的瓶颈，电子临床工具透过远端监控、穿戴式装置整合和即时回馈，提高了患者参与度。对互通性和云端平台日益增长的需求，进一步增强了临床试验系统的可扩展性和可存取性。人工智慧和机器学习正日益整合，以实现资料分析的自动化、试验风险识别和患者预后预测，从而提高营运效率并缩短试验时间。

儘管电子临床解决方案市场蓬勃发展，但仍面临许多挑战。实施和维护先进软体解决方案的高昂成本仍然是中小型申办方面的一大障碍。传统系统与现代平台之间的互通性问题往往会阻碍数位转型。资料隐私以及对不断发展的监管框架（例如《一般资料保护规范》(GDPR)、《健康保险流通与责任法》(HIPAA) 和 FDA 21 CFR 第 11 部分）的合规性，进一步加剧了市场复杂性。缺乏精通临床研究和数位技术的熟练专业人员，使得系统部署和采用变得困难。对网路安全、资料外洩以及远端试验技术可靠性的担忧也会影响利害关係人的信心。应对这些挑战对于持续的市场成长至关重要，重点在于标准化、供应商协作和监管协调。

关键市场驱动因素

增加生命科学研发投入

主要市场挑战

实施和营运成本高昂

主要市场趋势

分散和虚拟临床试验的快速成长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球电子临床解决方案市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（电子资料撷取 (EDC) 和临床资料管理系统 (CDMS)、临床试验管理系统 (CTMS)、临床分析平台、随机化和试验供应管理 (RTSM)、临床资料整合平台、电子临床结果评估 (eCOA)、安全解决方案、电子试验主文件 (eTMF)）
  • 依交付模式（基于云端和 Web、本地）
  • 依开发阶段（第一期、第二期、第三期、第四期）
  • 按最终用户（医院/医疗保健提供者、CRO、学术机构、製药和生物技术组织、医疗器材製造商）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美电子临床解决方案市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲电子临床解决方案市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：亚太地区电子临床解决方案市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美电子临床解决方案市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲电子临床解决方案市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Datatrak International, Inc.
• Oracle Corporation
• Parexel International Corporation
• ERT Clinical
• eClinicalWorks
• Anju Life Sciences Software
• eClinical Solutions
• RealTime Software Solutions, LLC
• Medidata Solution, Inc
• ICON, plc

第 16 章：策略建议

第17章调查会社について・免责事项

The Global eClinical Solutions Market was valued at USD 10.53 Billion in 2024 and is expected to reach USD 23.72 Billion by 2030 with a CAGR of 14.47%. The Global eClinical Solutions Market is undergoing rapid transformation as pharmaceutical, biotechnology, and contract research organizations (CROs) increasingly turn to digital tools to manage complex clinical trials more efficiently. As the demand for faster drug development intensifies, companies are seeking solutions that streamline data collection, management, and analysis. eClinical platforms such as electronic data capture (EDC), clinical trial management systems (CTMS), randomization and trial supply management (RTSM), and electronic patient-reported outcomes (ePRO) are now widely implemented to ensure real-time access to critical trial data and regulatory compliance. These solutions help accelerate decision-making, reduce human errors, and improve trial outcomes, making them indispensable in modern clinical research environments.

Key market drivers include rising R&D investment by pharmaceutical and biotech companies, growing prevalence of chronic diseases requiring advanced drug development, and the shift toward decentralized clinical trials. As patient recruitment and retention remain persistent bottlenecks in clinical research, eClinical tools provide better patient engagement through remote monitoring, wearable integration, and real-time feedback. The growing need for interoperability and cloud-based platforms further enhances scalability and accessibility of clinical trial systems. Artificial intelligence and machine learning are being increasingly integrated to automate data analytics, identify trial risks, and predict patient outcomes, improving operational efficiency and reducing trial timelines.

Despite its growth, the eClinical Solutions Market faces several challenges. The high cost of implementing and maintaining advanced software solutions continues to be a barrier for small and mid-sized sponsors. Interoperability issues between legacy systems and modern platforms often slow down digital transformation. Data privacy and compliance with evolving regulatory frameworks such as GDPR, HIPAA, and FDA 21 CFR Part 11 add further complexity. A shortage of skilled professionals with expertise in both clinical research and digital technologies makes system deployment and adoption difficult. Concerns around cybersecurity, data breaches, and the reliability of remote trial technologies can also affect stakeholder confidence. Addressing these challenges will be essential for sustained market growth, with emphasis on standardization, vendor collaboration, and regulatory harmonization.

Key Market Drivers

Increased R&D Investment in Life Sciences

Increased R&D investment in the life sciences sector is a key driver accelerating the growth of the Global eClinical Solutions Market. The U.S. government's National Institutes of Health (NIH) allocated nearly USD 48 billion to biomedical and behavioral research in FY 2023, with approximately USD 28 billion dedicated to clinical trials and related activities. This surge reflects a broader trend in rising clinical study volume, complexity, and regulatory rigor, prompting sponsors to adopt eClinical platforms. Tools like Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), and electronic Patient-Reported Outcomes (ePRO) systems are now essential for rapid data capture, real-time analytics, and regulatory compliance.

This expansion isn't limited to traditional pharmaceutical companies including academic institutions and biotech startups are also increasingly engaged in clinical research. In FY 2023, U.S. higher education institutions spent over USD 108.8 billion on R&D, an increase of 11.2% over the previous year. Many academic-led Phase I and II trials rely on digital infrastructure for accurate data handling. Global pressures to streamline trial timelines and reduce expenditure mean that digital solutions have become indispensable. Cloud-based systems provide scalable, interoperable environments that support real-time monitoring across multiple geographies, while predictive analytics enhance risk management and operational decision-making. These developments are increasing demand for advanced eClinical platforms capable of integrating with wearable devices, EHR systems, and AI-powered insights.

Real-world evidence (RWE) initiatives and regulatory endorsement of adaptive, patient-centric trial models are further bolstering digital trial technologies. With such robust R&D investment from federal agencies, universities, and private biotechs, it's clear why eClinical solutions are growing so rapidly. As clinical research transforms, digital infrastructure supporting it is expanding in scope and sophistication, firmly establishing the eClinical Solutions Market on a steep growth trajectory.

Key Market Challenges

High Implementation and Operational Costs

High implementation and operational costs represent a significant challenge in the Global eClinical Solutions Market, particularly for small and mid-sized pharmaceutical companies, biotech firms, and academic research institutions. Deploying eClinical platforms such as Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), and ePRO tools requires substantial upfront investment in software licensing, customization, validation, and IT infrastructure. These systems often need to be tailored to meet the specific requirements of a trial, which increases complexity and cost. The expense is not limited to initial deployment; it extends to ongoing maintenance, periodic software upgrades, user training, and cybersecurity measures, all of which add to the long-term financial burden.

For organizations operating with limited budgets or conducting fewer trials, justifying such high capital and operational expenditure becomes difficult. The cost of system validation and compliance with global regulatory standards such as 21 CFR Part 11 or GDPR adds another layer of expense. Training clinical staff to operate and manage these platforms can also be resource-intensive, especially in regions with limited access to skilled professionals. Smaller sponsors may opt for less sophisticated or manual processes, which can hinder data accuracy and slow down trial timelines. These cost-related barriers limit the widespread adoption of eClinical technologies and slow down digital transformation across the clinical research ecosystem.

Key Market Trends

Rapid Growth of Decentralized and Virtual Clinical Trials

The rapid growth of decentralized and virtual clinical trials is a defining trend in the global eClinical Solutions Market, reshaping how clinical research is conducted across geographies. Traditional site-based models are increasingly being replaced or supplemented by decentralized approaches that leverage digital technologies to enhance participant access, reduce logistical burdens, and accelerate trial timelines. eClinical platforms have become essential in enabling this shift, offering integrated solutions such as eConsent, electronic patient-reported outcomes (ePRO), wearable device integration, remote monitoring, and telehealth capabilities. These tools allow sponsors and CROs to collect real-time data from diverse patient populations without requiring physical site visits, thereby expanding recruitment and retention rates while minimizing disruptions.

The demand for decentralized trials is driven by the need to improve patient-centricity, increase data reliability, and reduce the high costs associated with on-site trial management. eClinical systems support these objectives by enabling seamless coordination between stakeholders, ensuring protocol compliance, and providing centralized oversight. Cloud-based platforms allow real-time data access and remote monitoring of safety parameters, which are crucial for adaptive trial designs and quick decision-making. Pharmaceutical companies and research organizations are adopting hybrid trial models that combine digital and on-site elements to optimize both operational flexibility and data quality. This growing reliance on decentralized models is reinforcing demand for scalable, interoperable, and secure eClinical technologies.

Key Market Players

• Datatrak International, Inc.
• Oracle Corporation
• Parexel International Corporation
• ERT Clinical
• eClinicalWorks
• Anju Life Sciences Software
• eClinical Solutions
• RealTime Software Solutions, LLC
• Medidata Solution, Inc
• ICON, plc

Report Scope:

In this report, the Global eClinical Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

eClinical Solutions Market, By Product:

• Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
• Clinical Trial Management Systems (CTMS)
• Clinical Analytics Platforms
• Randomization and Trial Supply Management (RTSM)
• Clinical Data Integration Platforms
• Electronic Clinical Outcome Assessment (eCOA)
• Safety Solutions
• Electronic Trial Master File (eTMF)

eClinical Solutions Market, By Delivery Mode:

• Cloud and Web-Based
• On-Premise

eClinical Solutions Market, By Development Phase:

• Phase I
• Phase II
• Phase III
• Phase IV

eClinical Solutions Market, By End User:

• Hospitals/Healthcare providers
• CROs
• Academic Institutes
• Pharma & Biotech Organizations
• Medical Device Manufacturers

eClinical Solutions Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global eClinical Solutions Market.

Available Customizations:

Global eClinical Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global eClinical Solutions Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM), Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, Electronic Trial Master File (eTMF))
  • 5.2.2. By Delivery Mode (Cloud and Web-Based, On-Premise)
  • 5.2.3. By Development Phase (Phase I, Phase II, Phase III, Phase IV)
  • 5.2.4. By End User (Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America eClinical Solutions Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Delivery Mode
  • 6.2.3. By Development Phase
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States eClinical Solutions Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Delivery Mode
      • 6.3.1.2.3. By Development Phase
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico eClinical Solutions Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Delivery Mode
      • 6.3.2.2.3. By Development Phase
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada eClinical Solutions Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Delivery Mode
      • 6.3.3.2.3. By Development Phase
      • 6.3.3.2.4. By End User

7. Europe eClinical Solutions Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Delivery Mode
  • 7.2.3. By Development Phase
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France eClinical Solutions Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Delivery Mode
      • 7.3.1.2.3. By Development Phase
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany eClinical Solutions Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Delivery Mode
      • 7.3.2.2.3. By Development Phase
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom eClinical Solutions Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Delivery Mode
      • 7.3.3.2.3. By Development Phase
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy eClinical Solutions Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Delivery Mode
      • 7.3.4.2.3. By Development Phase
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain eClinical Solutions Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Delivery Mode
      • 7.3.5.2.3. By Development Phase
      • 7.3.5.2.4. By End User

8. Asia-Pacific eClinical Solutions Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Delivery Mode
  • 8.2.3. By Development Phase
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China eClinical Solutions Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Delivery Mode
      • 8.3.1.2.3. By Development Phase
      • 8.3.1.2.4. By End User
  • 8.3.2. India eClinical Solutions Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Delivery Mode
      • 8.3.2.2.3. By Development Phase
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea eClinical Solutions Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Delivery Mode
      • 8.3.3.2.3. By Development Phase
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan eClinical Solutions Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Delivery Mode
      • 8.3.4.2.3. By Development Phase
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia eClinical Solutions Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Delivery Mode
      • 8.3.5.2.3. By Development Phase
      • 8.3.5.2.4. By End User

9. South America eClinical Solutions Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Delivery Mode
  • 9.2.3. By Development Phase
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil eClinical Solutions Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Delivery Mode
      • 9.3.1.2.3. By Development Phase
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina eClinical Solutions Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Delivery Mode
      • 9.3.2.2.3. By Development Phase
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia eClinical Solutions Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Delivery Mode
      • 9.3.3.2.3. By Development Phase
      • 9.3.3.2.4. By End User

10. Middle East and Africa eClinical Solutions Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Delivery Mode
  • 10.2.3. By Development Phase
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa eClinical Solutions Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Delivery Mode
      • 10.3.1.2.3. By Development Phase
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia eClinical Solutions Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Delivery Mode
      • 10.3.2.2.3. By Development Phase
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE eClinical Solutions Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Delivery Mode
      • 10.3.3.2.3. By Development Phase
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Datatrak International, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Oracle Corporation
• 15.3. Parexel International Corporation
• 15.4. ERT Clinical
• 15.5. eClinicalWorks
• 15.6. Anju Life Sciences Software
• 15.7. eClinical Solutions
• 15.8. RealTime Software Solutions, LLC
• 15.9. Medidata Solution, Inc
• 15.10. ICON, plc

16. Strategic Recommendations

17. About Us & Disclaimer